r rfn version 2007a (STATA Corporation)
99
Structured Review
STATA Corporation
r rfn version 2007a
R Rfn Version 2007a, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 2351 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+rfn+version+2007a/STATA+2%2E0/10__1158_slash_1078___0432__ccr___10___3278-103-21-32
Average 99 stars, based on 2351 article reviews
R Rfn Version 2007a, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 2351 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+rfn+version+2007a/STATA+2%2E0/10__1158_slash_1078___0432__ccr___10___3278-103-21-32
Average 99 stars, based on 2351 article reviews
r rfn version 2007a - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Concentration Assay:Article Title: Population Analysis of Erlotinib in Adults and Children Reveals Pharmacokinetic Characteristics as the Main Factor Explaining Tolerance Particularities in Children Article Snippet: Purpose: The aim of this pharmacokinetic–pharmacodynamic (PK–PD) analysis was to evaluate the pharmacologic characteristics of erlotinib and its main metabolite (OSI-420) in pediatric patients compared with those in adult patients.. Experimental Design: Plasma concentrations of erlotinib and OSI-420 of 46 children with malignant brain tumors included in a phase I study and 42 adults with head and neck carcinoma were analyzed by a population-pharmacokinetic method (NONMEM).. The effect of several covariates and single nucleotide polymorphisms (SNP) in ABCB1, ABCG2, andCYP3A5 on pharmacokinetic parameters was evaluated. |